Neil Sinha
Internal Medicine · Calhoun, GANPI 1427213826
Payments from drug & device makers
Across 231 payments — averaging $17.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$564
- AstraZeneca$421
- Vertos Medical, Inc.$259
- Merck$200
- GSK$181
- plus $1K from 28 others
What the payments were for
- Food & beverage$4,027100%
- Other$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 103 | $1,081 |
| Novo Nordisk | 25 | $564 |
| AstraZeneca | 13 | $421 |
| Vertos Medical, Inc. | 5 | $259 |
| Merck | 7 | $200 |
| GSK | 10 | $181 |
| Johnson & Johnson | 7 | $168 |
| Pfizer | 8 | $157 |
| Sanofi-aventis U.S. LLC | 2 | $119 |
| Lilly USA, LLC | 6 | $100 |
| Eisai Inc. | 5 | $76 |
| Otsuka America Pharmaceutical, Inc. | 4 | $66 |
| Lundbeck LLC | 3 | $61 |
| Arbor Pharmaceuticals, Inc. | 3 | $53 |
| Abbott | 3 | $50 |
| Amarin Pharma, Inc. | 3 | $47 |
| Bayer | 2 | $46 |
| Boehringer Ingelheim | 2 | $40 |
| Antares Pharma, Inc. | 2 | $35 |
| Mylan Specialty L.p. | 2 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Amgen | 2 | $30 |
| Biohaven Pharmaceuticals, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Kowa Pharmaceuticals America, Inc. | 1 | $23 |
| Nestle Healthcare Nutrition Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $18 |
| Medtronic | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Exact Sciences | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Baxter Healthcare | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$265
- mild Device Kit$168
- RYBELSUS$120
How this compares
$4,041 in reported general payments places this provider in the 85th percentile of 3,311 internal medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 15 | $28,689 |
| JardianceEmpagliflozin | 19 | $19,759 |
| EliquisApixaban | 23 | $18,131 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 11 | $7,439 |
| TradjentaLinagliptin | 11 | $6,000 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $2,508 |
| Levothyroxine Sodium | 121 | $1,200 |
| Atorvastatin Calcium | 106 | $830 |
| Rosuvastatin Calcium | 72 | $789 |
| Olmesartan Medoxomil | 44 | $763 |
| Telmisartan | 20 | $730 |
| Omeprazole | 59 | $709 |
| Lisinopril | 82 | $642 |
| Valsartan | 20 | $561 |
| Ezetimibe | 34 | $549 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $564 | $28,68915 claims |
| Boehringer IngelheimJardiance, Tradjenta | $40 | $25,75930 claims |
| PfizerEliquis | $157 | $18,13123 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,311 internal medicine providers in Georgia.
Other internal medicine in Calhoun
- Paul BradleySavannah$76.4M
- Kimball JohnsonAtlanta$51.1M
- Bram WieskopfWoodstock$21.9M
- Dwight BlakeUnion City$13.3M
- Charlotte Grayson-MathisFayetteville$9.6M
- Christopher RecknorGainesville$9.2M
- James HarperJohns Creek$9.2M
- Robert Springer IiiAtlanta$5.3M
- Thomas MoriaritySavannah$4.6M
- Charles KempAlbany$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.